Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock

Sacubitril/valsartan is a combination drug described as a new class of dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for heart failure. We present a case of a patient with NYHA class IV systolic heart failure who was refractory to all other classes of heart failure medications and was...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawal, H. A., Kocheril, A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976952/
https://www.ncbi.nlm.nih.gov/pubmed/29862089
http://dx.doi.org/10.1155/2018/8231576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976952/
https://www.ncbi.nlm.nih.gov/pubmed/29862089
http://dx.doi.org/10.1155/2018/8231576

Ejemplares similares